ATEZO-BRAIN, A Single-Arm Phase II Study of Atezolizumab Combined with Chemotherapy in Stage IV NSCLC Patients with Untreated Brain Metastases

Por: Nadal, E, Castro, RL, Juan, O, Huidobro, G, Carpeno, JD, Sullivan, IG, Bosch-Barrera, J, Campelo, RG, Estival, A, Blasco, A, Felip, E, Massuti, B, Guirado, M, Rodriguez-Abreu, D, Domine, M, Simo, M, Navarro, V and Bruna, J

---

Publicada: 1 oct 2019

---

---

Filiaciones:
Nadal, E:
 Inst Catala Oncologia, Med Oncol, Barcelona, Spain

Castro, RL:
 Univ Valladolid, Hosp Clin, Valladolid, Spain

Juan, O:
 Hosp Univ I Politecn La Fe, Valencia, Spain

Huidobro, G:
 Hosp Univ Vigo, Vigo, Spain

Carpeno, JD:
 Hosp Univ La Paz, Madrid, Spain

Sullivan, IG:
 Hosp La Santa Creu I Sant Pau, Barcelona, Spain

Bosch-Barrera, J:
 Catalan Inst Oncol, Hosp Univ Girona Doctor Josep Trueta, Girona, Brazil

Campelo, RG:
 Hosp Univ A Coruna, Coruna, Brazil

:
 Catalan Inst Oncol Badalona, Med Oncol, Badalona, Spain

 Hosp Univ Germans Trias i Pujol, Badalona, Spain

 B Argo, Badalona, Spain

 IGTP, Badalona, Spain

Blasco, A:
 Hosp Univ Gen Valencia Ciberonc, Valencia, Spain

Felip, E:
 Vall dHebron Inst Oncol, Barcelona, Spain

Massuti, B:
 Hosp Gen Univ Alicante, Alicante, Spain

Guirado, M:
 Hosp Univ Elche, Elche, Alicante, Spain

Rodriguez-Abreu, D:
 Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain

Domine, M:
 Hosp Fdn Jimenez Iis Fjd, Madrid, Spain

Simo, M:
 Hosp Univ Bellvitge Hosp, Barcelona, Spain

Navarro, V:
 Inst Catala Oncol, ed Oncol, Hosp Llobregat, Barcelona, Spain

Bruna, J:
 Hosp Univ Bellvitge Hosp, Barcelona, Spain